No connection

Search Results

ARMK

NEUTRAL
$39.08 Live
Aramark · NYSE
Target $44.6 (+14.1%)
$29.92 52W Range $44.49
Overview AI Snowflake Price Valuation Profitability Growth Health Peers Insiders

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$10.28B
P/E
32.3
ROE
10.5%
Profit margin
1.8%
Debt/Equity
1.81
Dividend yield
1.22%

AI Analysis

AI-powered fundamental assessment

Confidence
65%
ARMK's deterministic health signals are concerning, with a Piotroski F-Score of 4/9 indicating marginal financial stability and no available Altman Z-Score to confirm solvency safety. The stock trades at a significant premium to its Graham Number of $18.06 and intrinsic value of $8.47, supported by strong revenue growth and analyst optimism, but profitability and earnings trends are inconsistent. While the company shows top-line momentum and operates efficiently relative to peers in a highly leveraged sector, weak margins, declining earnings, and technical bearishness temper enthusiasm. Analysts recommend a 'buy', yet insider sentiment and trading activity are neutral, suggesting no strong conviction from insiders.

Key Strengths

Revenue growth of 14.3% YoY outpaces sector average despite macro pressures
Forward P/E of 15.09 suggests improved earnings expectations relative to current P/E of 32.30
ROE of 10.53% exceeds sector average of 6.23%, indicating efficient equity utilization
Debt/Equity of 1.81 is below the sector average of 6.14, reflecting better capital structure than peers
Analyst target price of $44.60 implies 14% upside, supported by 15 analysts

Key Risks

Piotroski F-Score of 4/9 indicates weak financial health with potential operational inefficiencies
Earnings declining YoY (-30.0%) and QoQ (-28.8%), signaling profit compression despite revenue growth
Current Ratio of 0.99 and Quick Ratio of 0.81 suggest near-term liquidity risk
Gross and net margins (15.67% and 1.76%) are well below sector averages, indicating pricing or cost challenges
Technical Trend score of 0/100 reflects strong bearish momentum over the short term
AI Fair Value Estimate
Based on comprehensive analysis
$28.5
-27.1% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
49
Moderate
Value
40
Future
55
Past
50
Health
42
Dividend
58
AI Verdict
Neutral with upside potential if earnings stabilize
Key drivers: Strong revenue growth and favorable forward valuation, Below-average leverage compared to sector, Weak profitability and declining earnings, Low Piotroski score and bearish technicals
Confidence
70%
Value
40/100

Ref P/E, PEG, Graham Number

Positives
  • Forward P/E of 15.09 is reasonable for expected recovery
  • Price/Sales of 0.56 is low, suggesting possible undervaluation on revenue basis
Watchpoints
  • Current P/E of 32.30 is high given negative earnings growth
  • Stock trades at 2.16x Graham Number ($18.06), indicating overvaluation on defensive criteria
  • Intrinsic value of $8.47 is far below current price, raising sustainability concerns
Future
55/100

Ref Growth rates

Positives
  • Revenue growth of 14.3% YoY indicates demand resilience
  • Most recent Q/Q EPS growth of +42.5% shows potential rebound in profitability
Watchpoints
  • Earnings down 30% YoY and 28.8% QoQ, indicating ongoing profit challenges
  • No PEG ratio due to unreliable or negative growth inputs
Past
50/100

Ref Historical trends

Positives
  • History of beating earnings estimates in 15 of last 25 quarters
  • Average earnings surprise of +5.6% over full track record
Watchpoints
  • Last 4 quarters have averaged a -3.33% surprise, showing deteriorating accuracy
  • Recent earnings misses in Nov 2025 and Feb 2026 after a prior streak of beats
Health
42/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • ROA of 4.11% is positive and stable
  • Debt/Equity of 1.81 is manageable and below sector norm
Watchpoints
  • Piotroski F-Score of 4/9 indicates weak financial health
  • Current and Quick Ratios below 1.0 signal short-term liquidity pressure
  • No Altman Z-Score available limits confidence in solvency assessment
Dividend
58/100

Ref Yield, Payout

Positives
  • Payout ratio of 34.43% is sustainable relative to earnings
  • Dividend Strength score of 40/100 suggests modest but stable commitment
Watchpoints
  • Dividend yield of 1.22% is below market average
  • No 5-year yield average available, limiting visibility on consistency

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$39.08
Analyst Target
$44.6
Upside/Downside
+14.1%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ARMK and closest competitors.

Updated 2026-01-23
ARM
Aramark
Primary
5Y
+61.1%
3Y
+25.2%
1Y
+2.9%
6M
-10.4%
1M
+3.5%
1W
-1.4%
DCI
Donaldson Company, Inc.
Peer
5Y
+54.2%
3Y
+47.0%
1Y
+37.2%
6M
+7.5%
1M
+2.1%
1W
-0.3%
ASR
Grupo Aeroportuario del Sureste, S. A. B. de C. V.
Peer
5Y
+162.2%
3Y
+35.0%
1Y
+32.3%
6M
+11.4%
1M
+2.4%
1W
+4.7%
AOS
A. O. Smith Corporation
Peer
5Y
+39.3%
3Y
+26.1%
1Y
+3.8%
6M
+1.6%
1M
+6.6%
1W
-0.0%
CR
Crane Company
Peer
5Y
+154.7%
3Y
+148.0%
1Y
+21.1%
6M
-5.9%
1M
+3.1%
1W
-6.6%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
32.3
Forward P/E
15.09
PEG Ratio
N/A
P/B Ratio
3.26
P/S Ratio
0.56
EV/Revenue
0.83
EV/EBITDA
11.56
Market Cap
$10.28B

Profitability

Profit margins and return metrics

Profit Margin 1.76%
Operating Margin 5.33%
Gross Margin 15.67%
ROE 10.53%
ROA 4.11%

Growth

Revenue and earnings growth rates

Revenue Growth +14.3%
Earnings Growth -30.0%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth -28.8%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
1.81
High debt
Current Ratio
0.99
Weak
Quick Ratio
0.81
Poor
Cash/Share
$2.43

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-10
$N/A
2025-11-17
$0.57
-12.7% surprise
2025-08-05
$0.4
+0.1% surprise
2025-05-06
$0.34
+2.7% surprise

Industrials Sector Comparison

Comparing ARMK against 469 companies in the Industrials sector (39 bullish, 174 neutral, 256 bearish)
P/E Ratio
32.3
This Stock
vs
98.24
Sector Avg
-67.1% (Discount)
Return on Equity (ROE)
10.53%
This Stock
vs
-19.38%
Sector Avg
-154.3% (Below Avg)
Profit Margin
1.76%
This Stock
vs
6.65%
Sector Avg
-73.5% (Weaker)
Debt to Equity
1.81
This Stock
vs
2.63
Sector Avg
-31.2% (Less Debt)
Revenue Growth
14.3%
This Stock
vs
71.29%
Sector Avg
-79.9% (Slower)
Current Ratio
0.99
This Stock
vs
3.09
Sector Avg
-67.9% (Weaker)

Similar Companies

Peer comparison within the same industry

ARMK Aramark
NEUTRAL
Mkt Cap
$10.3B
P/E
32.3
ROE
10.5%
Price
$39.08
DCI Donaldson Company, Inc.
BEARISH
Mkt Cap
$10.3B
P/E
27.8
ROE
24.3%
Price
$88.96
 Compare with ARMK
ASR Grupo...
NEUTRAL
Mkt Cap
$10.2B
P/E
13.1
ROE
23.0%
Price
$338.17
 Compare with ARMK
AOS A. O. Smith Corporation
NEUTRAL
Mkt Cap
$10.2B
P/E
19.7
ROE
28.2%
Price
$72.46
 Compare with ARMK
CR Crane Company
NEUTRAL
Mkt Cap
$10.4B
P/E
31.9
ROE
17.9%
Price
$180.08
 Compare with ARMK

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

DREILING RICHARD W
Director
Stock Award
2026-01-09
706 shares · $27,485
CREED GREG
Director
Stock Award
2026-01-09
866 shares · $33,713
SCHILLING CHRISTOPHER T
Officer
Stock Award
2025-12-17
49 shares
CHARPENTIER ABIGAIL
Officer
Stock Award
2025-12-17
149 shares
BRUNO MARC A
Officer
Stock Award
2025-12-17
187 shares
LOPEZ-GARCIA PATRICIA E
Director
Stock Award
2025-12-17
75 shares
TARANGELO JAMES J
Chief Financial Officer
Stock Award
2025-12-17
99 shares
KEVERIAN KENNETH M
Director
Stock Award
2025-12-17
75 shares
HARRINGTON LAUREN ANNE
General Counsel
Stock Award
2025-12-17
155 shares
KING KAREN MARIE
Director
Stock Award
2025-12-17
36 shares
DELGHIACCIO BRIAN M
Director
Stock Award
2025-12-17
35 shares
DREILING RICHARD W
Director
Stock Award
2025-12-17
24 shares
ZILLMER JOHN J
Chief Executive Officer
Stock Award
2025-12-17
1,372 shares
HELLER BRIDGETTE P
Director
Stock Award
2025-12-17
96 shares
SADOVE STEPHEN I
Director
Stock Award
2025-12-17
255 shares
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
15 analysts
Morgan Stanley
2025-12-17
Maintains
Equal-Weight Equal-Weight
Citigroup
2025-11-19
Maintains
Buy Buy
Morgan Stanley
2025-11-18
Maintains
Equal-Weight Equal-Weight
Baird
2025-11-18
Maintains
Outperform Outperform
UBS
2025-10-01
Maintains
Buy Buy
UBS
2025-08-06
Maintains
Buy Buy
Baird
2025-08-06
up
Neutral Outperform

Past News Coverage

Recent headlines mentioning ARMK from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI Chat
Markets
Profile